Company Encyclopedia
View More
name
Wellgistics Health
WGRX.US
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers.
226.15 B
WGRX.USMarket value -Rank by Market Cap -/-

Financial Score

14/12/2025 Update
C
Health Care DistributorsIndustry
Industry Ranking8/13
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-927.67%E
    • Profit Margin-228.17%E
    • Gross Margin7.67%E
  • Growth ScoreB
    • Revenue YoY495.93%A
    • Net Profit YoY-2059.44%E
    • Total Assets YoY-5.02%D
    • Net Assets YoY-32.12%E
  • Cash ScoreB
    • Cash Flow Margin-43.83%D
    • OCF YoY495.93%A
  • Operating ScoreB
    • Turnover0.63B
  • Debt ScoreE
    • Gearing Ratio87.16%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Wellgistics Health Launches Diabetes Drug Brenzavvy®

    Wellgistics Health, Inc. has launched its diabetes drug Brenzavvy® to its pharmacy network, targeting the $16 billion SGLT-2 inhibitor market in the US. The company uses its EinsteinRx™ AI platform to assist pharmacists with patient education, aiming to reduce out-of-pocket costs and enhance patient access. This launch establishes a new model for reformulated drug introductions in the market.

    TradingView·
    US
    WGRX
    -7.62%
    TradingView·
    US
    WGRX
    -7.62%

    Wellgistics Health Announces Launch of Diabetes Drug Brenzavvy(R) to Wellgistics Pharmacy Network | WGRX Stock News

    Wellgistics Health has launched Brenzavvy, a diabetes drug, targeting the $16 billion SGLT-2 inhibitor market. The launch aims to reduce out-of-pocket costs for 33 million type II diabetics in the US, leveraging the EinsteinRx AI platform to educate pharmacists and providers. Brenzavvy offers competitive pricing and patient-specific advantages, enhancing market access and care experience. The initiative supports pharmacist-led education to optimize therapy selection, especially in rural communities, and establishes a model for reformulated drugs to gain market share.

    StockTitan·
    US
    WGRX
    -7.62%
    StockTitan·
    US
    WGRX
    -7.62%

    Wellgistics Health Announces that it will Distribute a Dream Bowl 2026 Meme Coin to Wellgistics Health Stockholders

    Wellgistics Health, Inc. announced it will distribute the Dream Bowl 2026 Meme Coin to its stockholders. Shareholders will receive one coin per share owned as of December 19, 2025. The coin, a digital collectible, will be airdropped to shareholders' wallets and is intended for personal use related to the Dream Bowl 2026 event. It does not confer any financial rights or benefits. The distribution date will be set within 30 days after the record date, in coordination with DataVault AI, Inc.

    fidelity·
    US
    WGRX
    -7.62%
    fidelity·
    US
    WGRX
    -7.62%

    Wellgistics Health Announces Sponsorship of Dream Bowl 2026 and Participation in DataVault AI Dream Bowl 2026 Meme Coin Shareholder Distribution Plan | DVLT Stock News

    Wellgistics Health, Inc. (NASDAQ: WGRX) announces its sponsorship of Dream Bowl 2026 and participation in the DataVault AI Shareholder Distribution Plan. The company plans to distribute Dream Bowl 2026 Meme Coins to shareholders, with a record date expected in December 2025 and distribution in January 2026. The Meme Coin is a digital collectible for the Dream Bowl event, not intended as an investment or security. Wellgistics aims to enhance transparency and trust in healthcare through its AI-powered platform.

    StockTitan·
    US
    WGRX
    -7.62%
    StockTitan·
    US
    WGRX
    -7.62%

    Wellgistics Health Enters License Agreement with DataVault AI

    Wellgistics Health Inc. has entered a license agreement with DataVault AI to use intellectual property for blockchain-enabled smart contracts in the prescription drug industry. This $2.5 million deal aims to enhance Wellgistics' PharmacyChain™ technology, potentially positioning the company as a leader in the industry by reducing costs and improving efficiency. The partnership is expected to disrupt the industry by minimizing PBM rebates and increasing transparency for payers.

    Tip Ranks·
    US
    WGRX
    -7.62%
    Tip Ranks·
    US
    WGRX
    -7.62%
    © 2025 Longbridge｜Disclaimer